Activated Recombinant Human Factor VII in Pelvic-acetabular Fracture Reconstruction
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to evaluate the efficacy of
activated recombinant human factor VIIgiven in conjunction with standard therapy in patients
undergoing major orthopaedic surgery following traumatic pelvic or pelvic and acetabular
fractures.